596 related articles for article (PubMed ID: 26059239)
41. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
[TBL] [Abstract][Full Text] [Related]
43. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling.
Luo K; Gu X; Liu J; Zeng G; Peng L; Huang H; Jiang M; Yang P; Li M; Yang Y; Wang Y; Peng Q; Zhu L; Zhang K
Exp Cell Res; 2016 Sep; 347(1):105-113. PubMed ID: 27432651
[TBL] [Abstract][Full Text] [Related]
45. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of basic fibroblast growth factor increases cisplatin sensitivity in A549 non-small cell lung cancer cells.
He L; Meng Y; Zhang Z; Liu Y; Wang X
J Cancer Res Ther; 2018; 14(7):1519-1524. PubMed ID: 30589033
[TBL] [Abstract][Full Text] [Related]
47. Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin.
Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y
Med Sci Monit; 2018 Feb; 24():1104-1111. PubMed ID: 29469087
[TBL] [Abstract][Full Text] [Related]
48. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
49. miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells.
Lin C; Xie L; Lu Y; Hu Z; Chang J
Int J Mol Med; 2018 Apr; 41(4):2050-2058. PubMed ID: 29328427
[TBL] [Abstract][Full Text] [Related]
50. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway.
Chen P; Li J; Jiang HG; Lan T; Chen YC
Tumour Biol; 2015 May; 36(5):3591-9. PubMed ID: 25542235
[TBL] [Abstract][Full Text] [Related]
51. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
[TBL] [Abstract][Full Text] [Related]
52. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
53. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
54. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
55. WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.
Wang X; Bao Y; Dong Z; Chen Q; Guo H; Ziang C; Shao J
Oncotarget; 2017 Jul; 8(30):49033-49043. PubMed ID: 28446729
[TBL] [Abstract][Full Text] [Related]
56. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
Mattheolabakis G; Ling D; Ahmad G; Amiji M
Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
[TBL] [Abstract][Full Text] [Related]
57. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell.
Yang Y; Li H; Hou S; Hu B; Liu J; Wang J
PLoS One; 2013; 8(5):e65309. PubMed ID: 23741487
[TBL] [Abstract][Full Text] [Related]
58. Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway.
Gong X; Huang M
Cancer Gene Ther; 2017 Sep; 24(9):381-385. PubMed ID: 29027534
[TBL] [Abstract][Full Text] [Related]
59. miR‑139‑5p enhances cisplatin sensitivity in non‑small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox‑B2.
Du H; Bao Y; Liu C; Zhong A; Niu Y; Tang X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300085
[TBL] [Abstract][Full Text] [Related]
60. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]